Fundamental Analysis of AMYRIS INC(NASDAQ:AMRS) stock

Fundamental Rating

AMRS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. AMRS has a bad profitability rating. Also its financial health evaluation is rather negative. AMRS is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AMRS has reported negative net income.

AMRS had a negative operating cash flow in the past year.

AMRS had negative earnings in each of the past 5 years.

AMRS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The profitability ratios for AMRS are negative, so there is not much use analyzing them.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AMRS has a worse Gross Margin (3.38%) than 87.36% of its industry peers.

AMRS's Gross Margin has declined in the last couple of years.

AMRS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	3.38%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-54.8%

GM growth 5Y-38.18%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AMRS does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, AMRS has more shares outstanding

Compared to 5 years ago, AMRS has more shares outstanding

AMRS has a worse debt/assets ratio than last year.

2.2 Solvency

AMRS has an Altman-Z score of -9.17. This is a bad value and indicates that AMRS is not financially healthy and even has some risk of bankruptcy.

AMRS's Altman-Z score of -9.17 is on the low side compared to the rest of the industry. AMRS is outperformed by 90.80% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-9.17

ROIC/WACCN/A

WACC1.72%

2.3 Liquidity

A Current Ratio of 0.52 indicates that AMRS may have some problems paying its short term obligations.

AMRS has a Current ratio of 0.52. This is amonst the worse of the industry: AMRS underperforms 94.25% of its industry peers.

AMRS has a Quick Ratio of 0.52. This is a bad value and indicates that AMRS is not financially healthy enough and could expect problems in meeting its short term obligations.

AMRS has a Quick ratio of 0.29. This is amonst the worse of the industry: AMRS underperforms 95.40% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.52
Quick Ratio	0.29

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AMRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -595.83%.

The Revenue for AMRS has decreased by -32.87% in the past year. This is quite bad

The Revenue has been growing by 16.14% on average over the past years. This is quite good.

EPS 1Y (TTM)-595.83%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q2.94%

Revenue 1Y (TTM)-32.87%

Revenue growth 3Y20.93%

Revenue growth 5Y16.14%

Revenue growth Q2Q-2.82%

3.2 Future

AMRS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.70% yearly.

AMRS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.11% yearly.

EPS Next Y67.21%

EPS Next 2Y30.71%

EPS Next 3Y22.7%

EPS Next 5YN/A

Revenue Next Year76.61%

Revenue Next 2Y27.5%

Revenue Next 3Y26.8%

Revenue Next 5Y21.11%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMRS. In the last year negative earnings were reported.

Also next year AMRS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as AMRS's earnings are expected to grow with 22.70% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y30.71%

EPS Next 3Y22.7%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AMRS does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AMYRIS INC

NASDAQ:AMRS (8/18/2023, 7:19:54 PM)

After market: 0.052 +0 (+4%)

0.05

-0.01 (-21.87%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap18.47M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	3.38%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.39

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.52
Quick Ratio	0.29
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-595.83%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y67.21%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-32.87%

Revenue growth 3Y20.93%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

AMYRIS INC (AMRS)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens